Total Payments
$53,973
2024 Payments
$6,780
Companies
32
Transactions
545
Medicare Patients
3,202
Medicare Billing
$354,961
Payment Breakdown by Category
Other$39,690 (73.5%)
Food & Beverage$9,335 (17.3%)
Travel$4,886 (9.1%)
Education$62.22 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,690 | 23 | 73.5% |
| Food and Beverage | $9,335 | 493 | 17.3% |
| Travel and Lodging | $4,886 | 24 | 9.1% |
| Education | $62.22 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $12,882 | 74 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $12,657 | 30 | $0 (2023) |
| Gilead Sciences, Inc. | $11,775 | 41 | $0 (2019) |
| Mallinckrodt LLC | $11,453 | 42 | $0 (2018) |
| GlaxoSmithKline, LLC. | $1,362 | 78 | $0 (2024) |
| Genentech USA, Inc. | $872.73 | 95 | $0 (2024) |
| Mylan Specialty L.P. | $768.30 | 47 | $0 (2024) |
| Novo Nordisk Inc | $284.60 | 20 | $0 (2024) |
| Philips Electronics North America Corporation | $257.45 | 16 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $184.43 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,780 | 38 | AstraZeneca Pharmaceuticals LP ($6,429) |
| 2023 | $7,074 | 90 | AstraZeneca Pharmaceuticals LP ($5,885) |
| 2022 | $1,154 | 73 | GlaxoSmithKline, LLC. ($357.65) |
| 2021 | $579.38 | 36 | GlaxoSmithKline, LLC. ($247.10) |
| 2020 | $214.29 | 15 | Mylan Specialty L.P. ($39.04) |
| 2019 | $656.10 | 54 | Mylan Specialty L.P. ($171.22) |
| 2018 | $10,270 | 66 | Bayer HealthCare Pharmaceuticals Inc. ($5,751) |
| 2017 | $27,245 | 173 | Mallinckrodt LLC ($11,396) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 06/19/2024 | Dentsply Sirona Inc | Prime&Bond NT Nano-Technology Light Cured Dental Adhesive (Device) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Restorative Dentistry | ||||||
| 06/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $17.42 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $78.97 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $20.10 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $2.50 | General |
| Category: Respiratory | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Oncology | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 849 | 1,436 | $701,047 | $84,166 |
| 2022 | 14 | 814 | 1,405 | $658,377 | $84,169 |
| 2021 | 16 | 803 | 1,391 | $648,926 | $90,571 |
| 2020 | 14 | 736 | 1,386 | $221,007 | $96,055 |
Total Patients
3,202
Total Services
5,618
Medicare Billing
$354,961
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 318 | 784 | $465,897 | $54,946 | 11.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $59,319 | $7,134 | 12.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 116 | $37,700 | $4,914 | 13.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 89 | 93 | $36,586 | $4,759 | 13.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 94 | 98 | $28,560 | $3,356 | 11.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 69 | 72 | $21,489 | $2,797 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $22,245 | $2,758 | 12.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $12,780 | $1,446 | 11.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 17 | $5,732 | $745.35 | 13.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 15 | 16 | $3,624 | $475.04 | 13.1% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 26 | 28 | $1,787 | $236.88 | 13.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 22 | 22 | $1,632 | $211.68 | 13.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 21 | 21 | $1,333 | $172.80 | 13.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 24 | 24 | $1,990 | $172.27 | 8.7% |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | Office | 2023 | 15 | 17 | $340.00 | $41.68 | 12.3% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 13 | 33 | $33.00 | $0.86 | 2.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 305 | 695 | $416,127 | $53,502 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $54,750 | $7,511 | 13.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 123 | $30,135 | $3,927 | 13.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 39 | 50 | $29,850 | $3,580 | 12.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 57 | 57 | $23,347 | $3,080 | 13.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 23 | $19,688 | $2,594 | 13.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 58 | 58 | $17,473 | $2,393 | 13.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 59 | 60 | $16,217 | $2,122 | 13.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 48 | 53 | $19,973 | $1,546 | 7.7% |
About Dr. Robin Lucas, MD
Dr. Robin Lucas, MD is a Critical Care Medicine healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841286697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Lucas, MD has received a total of $53,973 in payments from pharmaceutical and medical device companies, with $6,780 received in 2024. These payments were reported across 545 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,690).
As a Medicare-enrolled provider, Lucas has provided services to 3,202 Medicare beneficiaries, totaling 5,618 services with total Medicare billing of $354,961. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Somerset, NJ
- Active Since 09/26/2005
- Last Updated 02/08/2017
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841286697
Products in Payments
- Adempas (Drug) $12,657
- ACTHAR (Biological) $11,494
- AIRSUPRA (Drug) $11,319
- Letairis (Drug) $2,175
- Xolair (Biological) $786.48
- FASENRA (Biological) $636.94
- NUCALA (Biological) $603.14
- TRELEGY ELLIPTA (Drug) $474.81
- Yupelri (Drug) $399.78
- BREZTRI (Drug) $392.34
- YUPELRI (Drug) $223.81
- DUPIXENT (Biological) $208.37
- (8874) inCourage (Device) $193.32
- TEZSPIRE (Biological) $185.88
- BEVESPI AEROSPHERE (Drug) $171.81
- TAGRISSO (Drug) $120.29
- AVYCAZ (Drug) $120.16
- TYVASO (Drug) $116.26
- Ozempic (Drug) $108.42
- XOLAIR (Biological) $94.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Somerset
Dr. Lawrence Davanzo, D.o, D.O
Critical Care Medicine — Payments: $24,714
Critical Care Medicine $24,714
Justin Lasure, Crna, CRNA
Critical Care Medicine — Payments: $57.98
Critical Care Medicine $57.98
Noah Hamilton, Crna, CRNA
Critical Care Medicine — Payments: $35.40
Critical Care Medicine $35.40
Andre Dauphinais, Rn, RN
Critical Care Medicine
Critical Care Medicine